-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$16.50281.06% Upside
Lumos Pharma, Inc. Frequently Asked Questions
-
What analysts cover Lumos Pharma, Inc.?
Lumos Pharma, Inc. has been rated by research analysts at Jefferies, Piper Sandler in the past 90 days.